KemPharm

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch KemPharm and buy or sell other stocks, options, and ETFs commission-free!

About KMPH

Zevra Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. 

CEO
Neil F. McFarlane
CEONeil F. McFarlane
Employees
69
Employees69
Headquarters
Celebration, Florida
HeadquartersCelebration, Florida
Founded
2006
Founded2006
Employees
69
Employees69

KMPH Key Statistics

Market cap
247.13M
Market cap247.13M
Price-Earnings ratio
-3.82
Price-Earnings ratio-3.82
Dividend yield
Dividend yield
Average volume
183.38K
Average volume183.38K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$7.28
52 Week high$7.28
52 Week low
$3.89
52 Week low$3.89
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.